Beeline Medicines emerges as Bristol Myers' partner for shelved immunology drugs
Beeline Medicines 成为百时美施贵宝搁置的免疫学药物合作伙伴

Bain Capital is implementing a blueprint that’s worked before, officially launching a company Wednesday with five assets from Bristol Myers Squibb.
贝恩资本正沿用一套行之有效的蓝图，周三正式成立了一家接手百时美施贵宝五项资产的公司。